Johnson & Johnson’s McNeil division, beset by an unstemmed tide of consumer product recalls, said Thursday that it had finalized a consent decree that would put three of its manufacturing facilities under supervision of U.S. health authorities.

McNeil said in a statement it had finalized the terms of a consent decree with the Food and Drug Administration for its facilities in Las Piedras, Puerto Rico, and Fort Washington and Lancaster, Pa.

McNeil said it expects the consent decree will govern its operation of the facilities for at least five years once a plan to rectify its problems is completed. It gave no details of the costs tied to the consent decree.

Johnson & Johnson shares fell 1.3 percent in late trading